Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07708831
What this trial is testing

Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Clarent Biopharma, Inc. 64
Early research (Phase 1)Study completedNCT03316521
What this trial is testing

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Who this might be right for
Complement Mediated Diseases
Amyndas Pharmaceuticals S.A. 50
Early research (Phase 1)Study completedNCT04467684
What this trial is testing

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Who this might be right for
Healthy Volunteers
Gilead Sciences 90
Testing effectiveness (Phase 2)Study completedNCT00088582
What this trial is testing

Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 62
Early research (Phase 1)Study completedNCT04036227
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

Who this might be right for
Healthy
Gesynta Pharma AB 72
Early research (Phase 1)Looking for participantsNCT07352423
What this trial is testing

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants

Who this might be right for
Healthy Adult Participants
Alexion Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT03287310
What this trial is testing

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Who this might be right for
Asthma
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT00928343
What this trial is testing

First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 18
Early research (Phase 1)Study completedNCT04535752
What this trial is testing

A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

Who this might be right for
Safety and Tolerability in Healthy Volunteers
Annexon, Inc. 48
Early research (Phase 1)Study completedNCT01512849
What this trial is testing

Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00340704
What this trial is testing

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Who this might be right for
Bladder, Neurogenic
Boehringer Ingelheim 143
Early research (Phase 1)Study completedNCT03334084
What this trial is testing

Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects

Who this might be right for
Bioavailability Study
argenx 40
Early research (Phase 1)Study completedNCT01316432
What this trial is testing

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Who this might be right for
Heart FailureADHFChronic Heart Failure+1 more
Nile Therapeutics 58
Early research (Phase 1)Study completedNCT01014416
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

Who this might be right for
Healthy
Korea Otsuka Pharmaceutical Co., Ltd. 46
Early research (Phase 1)UnknownNCT04866485
What this trial is testing

Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Who this might be right for
Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd. 66
Early research (Phase 1)Looking for participantsNCT07093255
What this trial is testing

Safety, PK and PD of FLQ-101 in Premature Neonates

Who this might be right for
Retinopathy of Prematurity (ROP)
FELIQS INC. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07644832
What this trial is testing

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Who this might be right for
Hemophilia AHemophilia BFactor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd. 76
Large-scale testing (Phase 3)Study completedNCT05378672
What this trial is testing

Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D

Who this might be right for
HypoglycemiaType 1 Diabetes
Zealand Pharma 8
Testing effectiveness (Phase 2)Study completedNCT06104319
What this trial is testing

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 61
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Next Page